Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

UT1501

Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores
Unstained: $215.00 Add to Cart
H&E (UT1501s*): $215.00 Add to Cart

Microarray Panel:Uterine endometrioid adenocarcinoma tissue microarray, containing 58 cases of uterus endometrioid adenocarcinoma, 2 each of uterus chorionic carcinoma and squamous cell carcinoma, 4 uterus adenosquamous carcinoma, 1 uterus clear cell carcinoma, 3 uterus stromal sarcoma, 2 atypical hyperplasia, plus 3 normal endometrium tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)
Cores:150
Cases:75
Layout:15 cols × 10 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112131415 
A Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
B Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
C Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
D Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
E Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
F Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
G Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
H Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
I Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
J Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Marked point
Legend: Ute - Uterus

- Hyperplasia, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIc), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic), - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 60 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A2 2 F 58 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
A3 3 F 44 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
A4 4 F 76 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
A5 5 F 60 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
A6 6 F 48 Uterus Adenocarcinoma (sparse) 2 Ib T1bN0M0 Malignant
A7 7 F 51 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A8 8 F 42 Uterus Adenocarcinoma (sparse) – Ia T1aN0M0 Malignant
A9 9 F 58 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
A10 10 F 65 Uterus Endometrioid adenocarcinoma (sparse) 2 Ic T1cN0M0 Malignant
A11 11 F 36 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A12 12 F 60 Uterus Endometrioid adenocarcinoma with necrosis 1 IIb T2bN0M0 Malignant
A13 13 F 40 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A14 14 F 45 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
A15 15 F 73 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
B1 16 F 60 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B2 17 F 58 Uterus Endometrioid adenocarcinoma (smooth muscle and blood vessel) – Ib T1bN0M0 Malignant
B3 18 F 44 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
B4 19 F 76 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
B5 20 F 60 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
B6 21 F 48 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B7 22 F 51 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B8 23 F 42 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B9 24 F 58 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B10 25 F 65 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
B11 26 F 36 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B12 27 F 60 Uterus Endometrioid adenocarcinoma with necrosis 1 IIb T2bN0M0 Malignant
B13 28 F 40 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B14 29 F 45 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B15 30 F 73 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
C1 31 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C2 32 F 65 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C3 33 F 55 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
C4 34 F 55 Uterus Endometrioid adenocarcinoma 2 IIa T2aN0M0 Malignant
C5 35 F 64 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C6 36 F 60 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C7 37 F 72 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C8 38 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C9 39 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C10 40 F 49 Uterus Endometrioid adenocarcinoma (sparse) 2 Ib T1bN0M0 Malignant
C11 41 F 58 Uterus Endometrioid adenocarcinoma 2–3 Ib T1bN0M0 Malignant
C12 42 F 62 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C13 43 F 74 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C14 44 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C15 45 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D1 46 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D2 47 F 65 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D3 48 F 55 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
D4 49 F 55 Uterus Endometrioid adenocarcinoma 2 IIa T2aN0M0 Malignant
D5 50 F 64 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D6 51 F 60 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D7 52 F 72 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D8 53 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D9 54 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D10 55 F 49 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D11 56 F 58 Uterus Endometrioid adenocarcinoma 2–3 Ib T1bN0M0 Malignant
D12 57 F 62 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D13 58 F 74 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D14 59 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D15 60 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E1 61 F 51 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
E2 62 F 66 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E3 63 F 51 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E4 64 F 58 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
E5 65 F 55 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
E6 66 F 56 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E7 67 F 54 Uterus Endometrioid adenocarcinoma 2 I T1N0M0 Malignant
E8 68 F 62 Uterus Endometrioid adenocarcinoma 2 IIIc T1cN1M0 Malignant
E9 69 F 67 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
E10 70 F 70 Uterus Endometrioid adenocarcinoma (sparse) 2 Ib T1bN0M0 Malignant
E11 71 F 54 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
E12 72 F 56 Uterus Endometrioid adenocarcinoma 3 Ia T1aN0M0 Malignant
E13 73 F 46 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E14 74 F 52 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
E15 75 F 51 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
F1 76 F 51 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F2 77 F 66 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F3 78 F 51 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F4 79 F 58 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F5 80 F 55 Uterus Endometrioid adenocarcinoma (sparse) 2 Ic T1cN0M0 Malignant
F6 81 F 56 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F7 82 F 54 Uterus Endometrioid adenocarcinoma 2 I T1N0M0 Malignant
F8 83 F 62 Uterus Endometrioid adenocarcinoma 2 IIIc T1cN1M0 Malignant
F9 84 F 67 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F10 85 F 70 Uterus Endometrioid adenocarcinoma (smooth muscle and blood vessel) – Ib T1bN0M0 Malignant
F11 86 F 54 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
F12 87 F 56 Uterus Endometrioid adenocarcinoma 3 Ia T1aN0M0 Malignant
F13 88 F 46 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F14 89 F 52 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
F15 90 F 51 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G1 91 F 52 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
G2 92 F 63 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G3 93 F 53 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G4 94 F 48 Uterus Endometrioid adenocarcinoma 3 III T3N0M0 Malignant
G5 95 F 56 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
G6 96 F 48 Uterus Endometrioid adenocarcinoma 2 II T2N0M0 Malignant
G7 97 F 58 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
G8 98 F 46 Uterus Endometrioid adenocarcinoma 3 IIb T2bN0M0 Malignant
G9 99 F 58 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G10 100 F 61 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G11 101 F 44 Uterus Endometrioid adenocarcinoma (tumoral necrosis) – Ib T1bN0M0 Malignant
G12 102 F 55 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G13 103 F 54 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G14 104 F 57 Uterus Chorionic carcinoma – Ic T1cN0M0 Malignant
G15 105 F 42 Uterus Chorionic carcinoma – Ic T1cN0M0 Malignant
H1 106 F 52 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
H2 107 F 63 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
H3 108 F 53 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
H4 109 F 48 Uterus Endometrioid adenocarcinoma 3 III T3N0M0 Malignant
H5 110 F 56 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
H6 111 F 48 Uterus Endometrioid adenocarcinoma 2 II T2N0M0 Malignant
H7 112 F 58 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
H8 113 F 46 Uterus Endometrioid adenocarcinoma 3 IIb T2bN0M0 Malignant
H9 114 F 58 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
H10 115 F 61 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
H11 116 F 44 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
H12 117 F 55 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
H13 118 F 54 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
H14 119 F 57 Uterus Chorionic carcinoma – Ic T1cN0M0 Malignant
H15 120 F 42 Uterus Chorionic carcinoma – Ic T1cN0M0 Malignant
I1 121 F 54 Uterus Adenosquamous carcinoma – IIb T2bN0M0 Malignant
I2 122 F 60 Uterus Adenosquamous carcinoma – IIa T2aN0M0 Malignant
I3 123 F 67 Uterus Adenosquamous carcinoma – IIa T2aN0M0 Malignant
I4 124 F 49 Uterus Adenosquamous carcinoma – Ic T1cN0M0 Malignant
I5 125 F 70 Uterus Clear cell carcinoma – Ib T1bN0M0 Malignant
I6 126 F 26 Uterus Stromal sarcoma – Ib T2N0M0G1 Malignant
I7 127 F 26 Uterus Stromal sarcoma – Ib T2N0M0G1 Malignant
I8 128 F 44 Uterus Stromal sarcoma – Ib T2N0M0G1 Malignant
I9 129 F 53 Uterus Squamous cell carcinoma 3 Ic T1cN0M0 Malignant
I10 130 F 55 Uterus Squamous cell carcinoma 3 Ic T1cN0M0 Malignant
I11 131 F 47 Uterus Atypical hyperplasia 2–3 – – Hyperplasia
I12 132 F 48 Uterus Mild hyperplasia – – – Hyperplasia
I13 133 F 21 Uterus Normal endometrium tissue – – – Normal
I14 134 F 21 Uterus Normal endometrium tissue – – – Normal
I15 135 F 18 Uterus Normal endometrium tissue – – – Normal
J1 136 F 54 Uterus Adenosquamous carcinoma – IIb T2bN0M0 Malignant
J2 137 F 60 Uterus Adenosquamous carcinoma (sparse) – IIa T2aN0M0 Malignant
J3 138 F 67 Uterus Adenosquamous carcinoma – IIa T2aN0M0 Malignant
J4 139 F 49 Uterus Adenosquamous carcinoma – Ic T1cN0M0 Malignant
J5 140 F 70 Uterus Clear cell carcinoma – Ib T1bN0M0 Malignant
J6 141 F 26 Uterus Stromal sarcoma – Ib T2N0M0G1 Malignant
J7 142 F 26 Uterus Stromal sarcoma – Ib T2N0M0G1 Malignant
J8 143 F 44 Uterus Stromal sarcoma – Ib T2N0M0G1 Malignant
J9 144 F 53 Uterus Squamous cell carcinoma 3 Ic T1cN0M0 Malignant
J10 145 F 55 Uterus Squamous cell carcinoma 3 Ic T1cN0M0 Malignant
J11 146 F 47 Uterus Atypical hyperplasia 2–3 – – Hyperplasia
J12 147 F 48 Uterus Atypical hyperplasia (smooth muscle and blood vessel) – – – Hyperplasia
J13 148 F 21 Uterus Normal endometrium tissue – – – Normal
J14 149 F 21 Uterus Normal endometrium tissue – – – Normal
J15 150 F 18 Uterus Normal endometrium tissue – – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal